Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Experimental & Molecular Medicine
>
2008
>
40
>
6
Volume:
40
Issue:
6
1. CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.
Page:658—668
2. Curcuminoid-phospholipid complex induces apoptosis in mammary epithelial cells by STAT-3 signaling.
Page:647—657
3. Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells.
Page:639—646
4. Inhibition of LPS-induced cyclooxygenase 2 and nitric oxide production by transduced PEP-1-PTEN fusion protein in Raw 264.7 macrophage cells.
Page:629—638
5. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Page:617—628
6. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Page:607—616
7. Protein kinase C micron plays an essential role in hypertonicity-induced heat shock protein 70 expression.
Page:596—606
8. Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.
Page:583—595
9. Ectopic expression of cyclooxygenase-2-induced dedifferentiation in articular chondrocytes.
Page:721—727
10. Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model.
Page:709—720
11. Transcription of the protein kinase C-delta gene is activated by JNK through c-Jun and ATF2 in response to the anticancer agent doxorubicin.
Page:699—708
12. Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion- induced liver injury by inhibiting NF-kappa B activation.
Page:686—698
13. Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers.
Page:677—685
14. Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation.
Page:669—676